Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Cardio Diagnostics Holdings (CDIOW) Gains from Investment Securities (2022 - 2025)

Historic Gains from Investment Securities for Cardio Diagnostics Holdings (CDIOW) over the last 4 years, with Q3 2025 value amounting to $135096.0.

  • Cardio Diagnostics Holdings' Gains from Investment Securities rose 475.32% to $135096.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $135096.0, marking a year-over-year increase of 475.32%. This contributed to the annual value of $3.6 million for FY2024, which is 3906.23% up from last year.
  • According to the latest figures from Q3 2025, Cardio Diagnostics Holdings' Gains from Investment Securities is $135096.0, which was up 475.32% from $128860.0 recorded in Q2 2025.
  • Over the past 5 years, Cardio Diagnostics Holdings' Gains from Investment Securities peaked at $3.6 million during Q4 2024, and registered a low of $122332.0 during Q1 2025.
  • Its 4-year average for Gains from Investment Securities is $1.4 million, with a median of $1.8 million in 2022.
  • In the last 5 years, Cardio Diagnostics Holdings' Gains from Investment Securities skyrocketed by 4688.57% in 2023 and then plummeted by 9510.34% in 2024.
  • Over the past 4 years, Cardio Diagnostics Holdings' Gains from Investment Securities (Quarter) stood at $1.8 million in 2022, then surged by 46.89% to $2.6 million in 2023, then skyrocketed by 39.06% to $3.6 million in 2024, then plummeted by 96.24% to $135096.0 in 2025.
  • Its Gains from Investment Securities stands at $135096.0 for Q3 2025, versus $128860.0 for Q2 2025 and $122332.0 for Q1 2025.